Growth Metrics

Glaukos (GKOS) Long-Term Debt Repayments (2015)

Glaukos (GKOS) reported Long-Term Debt Repayments of $6.9 million for Q1 2015.

Glaukos (GKOS) has 1 years of Long-Term Debt Repayments data on file, last reported at $6.9 million in Q1 2015.

  • Quarterly Long-Term Debt Repayments changed N/A year-over-year to $6.9 million in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $6.9 million (changed N/A YoY) and the FY2024 annual result came in at $712000.0, changed N/A from the prior year.
  • Long-Term Debt Repayments was little changed at $6.9 million in Q1 2015 per GKOS's latest filing.
  • Across five years, Long-Term Debt Repayments topped out at $6.9 million in Q1 2015 and bottomed at $6.9 million in Q1 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.42 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.00 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Glaukos 6.00 Bn 5.90 Bn 117.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2015 6.85 Mn
Mar 31, 2015 6.85 Mn